29MAY

Rivan raises £25m for Europe's biggest SNG plant

3 min read

14:17UTC

A Wiltshire startup pulled IQ Capital, Plural, and a European founder-angel trio onto its cap table to build synthetic gas at 15MW scale.

← Back to Orbital's $50m has no UK lead Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Rivan's angel syndicate shows UK cleantech can scale outside state programmes if European operator capital backs it.

Rivan, founded by Harvey Hodd, raised £25m on 20 April 2026 to build Project Steadfast, a 15MW synthetic natural gas plant in Wiltshire. IQ Capital led with Plural; angel investors included Matt Clifford of Entrepreneur First, Thomas Wolf of Hugging Face, and Markus Villig of Bolt. Total raised now stands at $46m, and the company has a commercial offtake partnership with Wales & West Utilities.

Synthetic natural gas (SNG) is methane manufactured from captured CO2 and green hydrogen rather than extracted from a well. The output is molecularly identical to fossil gas, meaning it runs on existing pipeline infrastructure, boilers, and industrial burners without replacement capex; that substitutability is the commercial proposition. Project Steadfast's 15MW scale makes it Europe's largest SNG facility and the first to inject SNG directly into the UK gas grid.

Four backers, four distinct European pedigrees. IQ Capital is a Cambridge deep-tech VC; Plural is a European fund founded by the Skype and Wise operators. The three angels each founded a category-defining European company: Clifford's Entrepreneur First runs the continent's largest talent-first accelerator; Wolf co-founded the AI platform Hugging Face; Villig built Bolt into Europe's largest ride-hailing operator by vehicle count. A cleantech startup pulling that mix of operator angels onto a grid-injection project is a signal about where European founder capital is migrating, and it is not toward the same US-dominated climate funds that dominated the last boom.

The cleantech vertical sits outside the UK's main targeted state-capital corridors. SAIU targets AI , ProQure targets quantum , LSIMF targets life sciences, and there is no equivalent multi-billion programme specifically for synthetic fuels. Rivan demonstrates that UK cleantech can still assemble material capital through VC plus founder-angel syndication at single-digit-£10m ticket sizes, though the ceiling on that mechanism is £25m, not £250m.

Deep Analysis

In plain English

Synthetic natural gas (SNG) is made by converting hydrogen into a gas that works exactly like the natural gas already in UK homes and factories. Rivan is building Europe's biggest factory for this process in Wiltshire, and it will be the first time this kind of gas has been pumped directly into the UK gas grid. The advantage is that industries using gas-powered furnaces or boilers do not need to change their equipment; they just switch to a cleaner version of the fuel they already use. The investors include the founders of Hugging Face and Bolt, two very well-known European tech companies, which is unusual for what is essentially an energy infrastructure project.

Deep Analysis

Root Causes

Natural gas demand from industries that cannot electrify; glass furnaces, ceramics, food processing, steel reheating; is projected to persist at 30-40% of current UK industrial gas consumption through 2040 per National Grid ESO's Future Energy Scenarios (2025); SNG from green hydrogen is the only currently technically viable substitute that does not require those industries to refit their combustion equipment.

The UK's hydrogen strategy (2021) allocated £240m to hydrogen production but did not create a mandatory blending target for the gas grid, leaving SNG injection commercially marginal without a voluntary green premium; Rivan's angel syndicate; Clifford, Wolf, Villig; reflects the project's dependence on conviction capital rather than policy-backed debt.

What could happen next?

Consequence
Project Steadfast will be the first commercial test of whether the UK gas grid's metering infrastructure can issue Renewable Gas Guarantees of Origin for SNG at MW scale; if Wales and West Utilities cannot certify the injection, the project's revenue model collapses to commodity gas pricing and Rivan will need a Contracts for Difference application to reach Series B.
Opportunity
A successful 15MW SNG injection at Wiltshire gives Rivan a replicable template for sites near industrial gas clusters; Teesside, Humber, Grangemouth; where hard-to-abate manufacturing demand is concentrated and grid injection capacity already exists, unlocking a pipeline of 10-15 further sites without new grid infrastructure.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: The UK's Renewable Heat Incentive (RHI), launched 2011, created the first revenue mechanism for biomethane injection into the gas grid; by 2020, approximately 100 biomethane plants had connected to the UK gas grid under RHI subsidy, demonstrating that grid injection at Rivan's scale is operationally proven.

Rivan's SNG is produced from hydrogen rather than organic feedstock, but the grid injection mechanism; and the dependency on a regulated tariff for project economics; follows the same RHI template.

Counter-parallel: GreenGas Hub's 2022 demonstration at Swindon injected hydrogen-derived SNG at 2MW scale and found that the economics were viable only with a Contracts for Difference-style floor price; without government offtake support, the project could not access debt finance.

Rivan's £25m from IQ Capital is equity, not debt, which suggests the current business model does not yet include a CfD anchor; a gap that Project Steadfast will need to address before reaching commercial scale above 50MW.

At Rivan's 15MW scale, Project Steadfast produces approximately 130GWh of SNG per year, worth roughly £6.5m at current UK gas spot prices.

The breakeven economics require either a green gas premium of approximately £25/MWh above commodity gas price or continued reduction in electrolyser capital costs below £500/kW. IQ Capital's investment implies a projected scale-up pathway to 100MW-plus at which unit economics become self-sustaining without subsidy.

Consensus view: The Carbon Trust's industrial decarbonisation team places SNG from green hydrogen in the second tier of hard-to-abate fuel substitution: below direct electrification but above carbon capture on abatement cost per tonne, at approximately £120-£180/tCO2 avoided at current electrolyser costs.

Rivan's 15MW plant at Wiltshire, producing SNG for grid injection, sits in the precise application window the Carbon Trust models as viable by 2028 once electrolyser learning curves reduce capital costs by 30-40%.

Counter-view: Aurora Energy Research notes that UK gas grid injection of SNG creates a blending problem: the gas grid is not currently instrumented to track SNG concentration at distribution level, meaning Rivan's injected gas will be indistinguishable from fossil gas in end-user billing systems, which prevents consumer-facing green premium pricing and limits the financial case for industrial buyers willing to pay for verified decarbonisation.

Key tension: Whether Wales and West Utilities' metering infrastructure can verify SNG injection volumes at sufficient granularity to support Renewable Gas Guarantees of Origin certificates; the mechanism that would allow Rivan to monetise the green premium; or whether the injection value is limited to the commodity gas price with no sustainability uplift.

Sources:City AM

Mentions:Rivan →Plural →Matt Clifford →Thomas Wolf →Markus Villig →Entrepreneur First →Hugging Face →Bolt →Wales →Cambridge →ProQure →Project Steadfast →Harvey Hodd →Wiltshire →Sovereign AI Unit →Venture Capital Trusts →Life Sciences Innovative Manufacturing Fund →

First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

City AM· 22 Apr 2026

Read original →

Causes and effects

This Event

Rivan raises £25m for Europe's biggest SNG plant

Rivan's syndicate pairs UK deep-tech VC with three European category-defining founders, a pattern that routes scale-up validation to UK cleantech without VCT dependency.

Led to

Nyobolt hits £1bn on Symbotic-led Series C

IQ Capital's participation in Nyobolt Series C continues its pattern of anchoring Cambridge deeptech spinout rounds alongside strategics, as it did in the Rivan raise (ID:2702).

Occurred 6 May 2026

Read story →

Mykor's £4m grows panels from mushrooms

Rivan's £25m cleantech raise in Wiltshire (ID:2702) showed regional, non-Golden-Triangle deeptech capital continues to flow outside AI; Mykor's £4m Bristol raise echoes that pattern.

Occurred 27 May 2026

Read story →

Different Perspectives

European limited partners (Plural, Aviva Investors)

Pan-European fund Plural led Orbital's $50m and Aviva Investors co-anchored the BBB's Lansdowne spinout fund (event ID:3505), demonstrating that Continental and UK institutional capital can fill the growth-stage tier independently, though neither has the scale to compete with US growth funds at the $100m+ band that successive ex-DeepMind rounds will eventually reach.

France (DSIT / GENCI / Institut Pasteur)

France signed the UK-France Strategic Biomedical Alliance on 29 May, contributing €330,000 a year to researcher mobility and linking GENCI national compute to Isambard-AI; the bilateral format suits Paris because it produces scientific access without requiring EU-framework ratification while the UK-EU science relationship remains unsettled.

US growth investors (NVentures, General Catalyst, Crosspoint Capital)

NVentures entering Orbital's cap table for the first time and General Catalyst following on in Geordie's Series A signals US growth investors treating London deeptech as a buy-side opportunity the UK market cannot contest. NVentures gains supply-chain visibility into GPU cooling; General Catalyst gains a frontier security category the RSAC prize has already validated for US enterprise.

UK Government (DSIT / British Business Bank)

The BBB cornerstoned Longwall at the seed floor on 27 May while DSIT signed the UK-France bilateral compute deal the same week, deploying state capital at bottom and research layers simultaneously. Neither instrument addresses the Series B middle the April 2026 mandate expansion could reach but has not.

Australian Department of Defence (AUKUS partner, Rowden Technologies)

Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May places UK sovereign capital directly into a trilateral programme Australia co-funds; from Canberra's perspective, the NWF cheque increases UK government skin-in-the-game on a programme where Australia has already committed co-development resources.

Temasek (Singapore sovereign co-investor, Isomorphic Series B)

Temasek co-invested with the SAIU in Isomorphic's $2.1bn Series B the previous week, treating a majority Alphabet-owned company as a valid sovereign co-investment target. Fractile's round, without a UK sovereign co-investor, reads differently from Singapore's vantage: allied state capital (NATO-IF, In-Q-Tel) is now competing with Asian sovereign funds for early positions in UK deeptech.